Tapewire

Nasdaq · USD

WVE

Wave Life Sciences, Inc.

Export transactions ↓
Tapewire entity
4976
SEC CIK
0001631574
Parsed reports
248

Last 12 months

Inside the activity.

6 purchase rows · 47 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202511
Dec 2025134
Jan 202602
Feb 202606
Mar 202640
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202604
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 11, 2025 Filed Aug 14, 2025 00:00 UTC GrantShare Option (right to buy) · Derivative 76,200 $0.00 Strike: $8.11 $0.00
Disclosure

SEC source: 0000950170-25-108288 · ownership.xml · derivative · entry 2

Wagner Heidi L · CIK 0001655029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,200

Underlying: Ordinary Shares · 76,200 shares

Expires 2030-08-11

F2 · derivative.exercise_date: The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026.

Read SEC document
August 11, 2025 Filed Aug 14, 2025 00:00 UTC GrantOrdinary Shares 12,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108288 · ownership.xml · nonDerivative · entry 1

Wagner Heidi L · CIK 0001655029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,930

F1 · shares: The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026.

Read SEC document
August 05, 2025 Filed Aug 8, 2025 00:00 UTC SaleOrdinary Shares 4,872 $8.75 $42,630.00
Disclosure

SEC source: 0000950170-25-105353 · ownership.xml · nonDerivative · entry 1

TAKANASHI KEN · CIK 0001657768 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,716,303

F1 · shares: On August 5, 2025, the reporting person sold 4,872 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025. These sales were made pursuant to a 10b5-1 Trading Plan.

Read SEC document
August 05, 2025 Filed Aug 8, 2025 00:00 UTC
Tan Aik NaDirector
SaleOrdinary Shares 1,127 $8.75 $9,861.25
Disclosure

SEC source: 0000950170-25-105352 · ownership.xml · nonDerivative · entry 1

Tan Aik Na · CIK 0001821285 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,988

F1 · shares: On August 5, 2025, the reporting person sold 1,127 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025.These sales were made pursuant to a 10b5-1 Trading Plan.

Read SEC document
June 13, 2025 Filed Jun 13, 2025 20:00 UTC SaleOrdinary Shares 30,000 $6.95 $208,500.00
Disclosure

SEC source: 0000950170-25-086466 · ownership.xml · nonDerivative · entry 1

Verdine Gregory L. · CIK 0001572315 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 282,517

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $6.79 to $7.04 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 20, 2025 Filed Mar 22, 2025 01:00 UTC Exercise / conversionShare Option (right to buy) · Derivative 10,500 $0.00 Strike: $9.13 $0.00
Disclosure

SEC source: 0000950170-25-043440 · ownership.xml · derivative · entry 3

HENRY CHRISTIAN O · CIK 0001263805 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,500 shares

Expires 2025-08-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024.

F3 · derivative.exercise_date: These share options are fully vested and have an expiration date of August 18, 2025.

Read SEC document
March 20, 2025 Filed Mar 22, 2025 01:00 UTC SaleOrdinary Shares 10,500 $9.77 $102,574.50
Disclosure

SEC source: 0000950170-25-043440 · ownership.xml · nonDerivative · entry 2

HENRY CHRISTIAN O · CIK 0001263805 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,115

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024.

F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.69 to $9.88 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 20, 2025 Filed Mar 22, 2025 01:00 UTC Exercise / conversionOrdinary Shares 10,500 $9.13 $95,865.00
Disclosure

SEC source: 0000950170-25-043440 · ownership.xml · nonDerivative · entry 1

HENRY CHRISTIAN O · CIK 0001263805 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024.

Read SEC document
March 07, 2025 Filed Mar 8, 2025 02:05 UTC
BOLNO PAULDirector · President and CEO
Exercise / conversionShare Option (right to buy) · Derivative 48,059 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-25-035835 · ownership.xml · derivative · entry 4

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 48,059 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

F3 · derivative.exercise_date: These share options are fully vested and have an expiration date of Monday, March 10, 2025.

Read SEC document
March 07, 2025 Filed Mar 8, 2025 02:05 UTC
BOLNO PAULDirector · President and CEO
Exercise / conversionShare Option (right to buy) · Derivative 120,966 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-25-035835 · ownership.xml · derivative · entry 3

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 120,966 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

F3 · derivative.exercise_date: These share options are fully vested and have an expiration date of Monday, March 10, 2025.

Read SEC document
March 07, 2025 Filed Mar 8, 2025 02:05 UTC
BOLNO PAULDirector · President and CEO
SaleOrdinary Shares 169,025 $9.57 $1,617,569.25
Disclosure

SEC source: 0000950170-25-035835 · ownership.xml · nonDerivative · entry 2

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 338,351

F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.12 to $10.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 07, 2025 Filed Mar 8, 2025 02:05 UTC
BOLNO PAULDirector · President and CEO
Exercise / conversionOrdinary Shares 169,025 $2.48 $419,182.00
Disclosure

SEC source: 0000950170-25-035835 · ownership.xml · nonDerivative · entry 1

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 507,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

Read SEC document
March 07, 2025 Filed Mar 7, 2025 21:00 UTC Exercise / conversionShare Option (right to buy) · Derivative 133,402 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-25-035834 · ownership.xml · derivative · entry 4

Verdine Gregory L. · CIK 0001572315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 133,402 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Read SEC document
March 07, 2025 Filed Mar 7, 2025 21:00 UTC Exercise / conversionOrdinary Shares 133,402 $2.48 $330,836.96
Disclosure

SEC source: 0000950170-25-035834 · ownership.xml · nonDerivative · entry 2

Verdine Gregory L. · CIK 0001572315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,517

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:00 UTC Exercise / conversionShare Option (right to buy) · Derivative 133,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-25-035834 · ownership.xml · derivative · entry 3

Verdine Gregory L. · CIK 0001572315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,402

Underlying: Ordinary Shares · 133,000 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:00 UTC Exercise / conversionOrdinary Shares 133,000 $2.48 $329,840.00
Disclosure

SEC source: 0000950170-25-035834 · ownership.xml · nonDerivative · entry 1

Verdine Gregory L. · CIK 0001572315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 17:14 UTC
Vargeese ChandraSee Remarks
Exercise / conversionShare Option (right to buy) · Derivative 75,332 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-25-033838 · ownership.xml · derivative · entry 3

Vargeese Chandra · CIK 0001657675 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 75,332 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 17:14 UTC
Vargeese ChandraSee Remarks
Exercise / conversionShare Option (right to buy) · Derivative 16,422 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-25-033838 · ownership.xml · derivative · entry 2

Vargeese Chandra · CIK 0001657675 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 16,422 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 17:14 UTC
Vargeese ChandraSee Remarks
Exercise / conversionOrdinary Shares 91,754 $2.48 $227,549.92
Disclosure

SEC source: 0000950170-25-033838 · ownership.xml · nonDerivative · entry 1

Vargeese Chandra · CIK 0001657675 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 362,687

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 04, 2025 Filed Feb 6, 2025 20:00 UTC
Vargeese ChandraSee Remarks
GrantShare Option (right to buy) · Derivative 224,000 $0.00 Strike: $11.74 $0.00
Disclosure

SEC source: 0000950170-25-015679 · ownership.xml · derivative · entry 2

Vargeese Chandra · CIK 0001657675 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,000

Underlying: Ordinary Shares · 224,000 shares

Expires 2035-02-04

F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029.

Read SEC document
February 04, 2025 Filed Feb 6, 2025 20:00 UTC
Vargeese ChandraSee Remarks
GrantOrdinary Shares 37,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-015679 · ownership.xml · nonDerivative · entry 1

Vargeese Chandra · CIK 0001657675 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,933

F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029.

Read SEC document
February 04, 2025 Filed Feb 6, 2025 20:00 UTC
Francis ChrisSee Remarks
GrantShare Option (right to buy) · Derivative 151,000 $0.00 Strike: $11.74 $0.00
Disclosure

SEC source: 0000950170-25-015680 · ownership.xml · derivative · entry 2

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,000

Underlying: Ordinary Shares · 151,000 shares

Expires 2035-02-04

F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029.

Read SEC document
February 04, 2025 Filed Feb 6, 2025 20:00 UTC
Francis ChrisSee Remarks
GrantOrdinary Shares 25,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-015680 · ownership.xml · nonDerivative · entry 1

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:00 UTC
BOLNO PAULDirector · President and CEO
GrantShare Option (right to buy) · Derivative 1,000,000 $0.00 Strike: $11.74 $0.00
Disclosure

SEC source: 0000950170-25-015681 · ownership.xml · derivative · entry 2

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Ordinary Shares · 1,000,000 shares

Expires 2035-02-04

F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:00 UTC
BOLNO PAULDirector · President and CEO
GrantOrdinary Shares 121,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-015681 · ownership.xml · nonDerivative · entry 1

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,351

F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:00 UTC
Moran KyleChief Financial Officer
GrantShare Option (right to buy) · Derivative 252,000 $0.00 Strike: $11.74 $0.00
Disclosure

SEC source: 0000950170-25-015682 · ownership.xml · derivative · entry 2

Moran Kyle · CIK 0001657765 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,000

Underlying: Ordinary Shares · 252,000 shares

Expires 2035-02-04

F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029.

Read SEC document
February 04, 2025 Filed Feb 7, 2025 01:00 UTC
Moran KyleChief Financial Officer
GrantOrdinary Shares 42,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-015682 · ownership.xml · nonDerivative · entry 1

Moran Kyle · CIK 0001657765 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,218

F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029.

F2 · balance_after: Includes 2,441 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.

Read SEC document
January 23, 2025 Filed Jan 24, 2025 17:30 UTC
Vargeese ChandraSee Remarks
Exercise / conversionShare Option (right to buy) · Derivative 46,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-25-008909 · ownership.xml · derivative · entry 2

Vargeese Chandra · CIK 0001657675 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,422

Underlying: Ordinary Shares · 46,000 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Read SEC document
January 23, 2025 Filed Jan 24, 2025 17:30 UTC
Vargeese ChandraSee Remarks
Exercise / conversionOrdinary Shares 46,000 $2.48 $114,080.00
Disclosure

SEC source: 0000950170-25-008909 · ownership.xml · nonDerivative · entry 1

Vargeese Chandra · CIK 0001657675 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,872 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.

Read SEC document
November 25, 2024 Filed Nov 28, 2024 02:00 UTC
BOLNO PAULDirector · President and CEO
Exercise / conversionShare Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-24-131691 · ownership.xml · derivative · entry 3

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,778

Underlying: Ordinary Shares · 50,000 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

F2 · derivative.exercise_date: These share options are fully vested.

Read SEC document
November 25, 2024 Filed Nov 28, 2024 02:00 UTC
BOLNO PAULDirector · President and CEO
SaleOrdinary Shares 50,000 $15.00 $750,000.00
Disclosure

SEC source: 0000950170-24-131691 · ownership.xml · nonDerivative · entry 2

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,351

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

Read SEC document
November 25, 2024 Filed Nov 28, 2024 02:00 UTC
BOLNO PAULDirector · President and CEO
Exercise / conversionOrdinary Shares 50,000 $2.48 $124,000.00
Disclosure

SEC source: 0000950170-24-131691 · ownership.xml · nonDerivative · entry 1

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 267,351

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

Read SEC document
November 15, 2024 Filed Nov 16, 2024 02:00 UTC
BOLNO PAULDirector · President and CEO
SaleOrdinary Shares 51,234 $14.32 $733,670.88
Disclosure

SEC source: 0000950170-24-127740 · ownership.xml · nonDerivative · entry 1

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,351

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024.

F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.11 to $15.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionShare Option (right to buy) · Derivative 36,000 $0.00 Strike: $8.17 $0.00
Disclosure

SEC source: 0000950170-24-126622 · ownership.xml · derivative · entry 3

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 36,000 shares

Expires 2030-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The share options that were exercised in this reportable transaction were fully vested.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 20:00 UTC
Francis ChrisSee Remarks
SaleOrdinary Shares 36,000 $16.00 $576,000.00
Disclosure

SEC source: 0000950170-24-126622 · ownership.xml · nonDerivative · entry 2

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionOrdinary Shares 36,000 $8.17 $294,120.00
Disclosure

SEC source: 0000950170-24-126622 · ownership.xml · nonDerivative · entry 1

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionShare Option (right to buy) · Derivative 22,500 $0.00 Strike: $2.83 $0.00
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · derivative · entry 10

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Ordinary Shares · 22,500 shares

Expires 2032-07-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The share options that were exercised in this reportable transaction were fully vested.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionShare Option (right to buy) · Derivative 65,625 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · derivative · entry 9

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,375

Underlying: Ordinary Shares · 65,625 shares

Expires 2032-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The share option represented the right to purchase a total of 150,000 ordinary shares, 25% of which became exercisable on January 1, 2023, and the remaining shares vest as to an additional 6.25% quarterly thereafter until January 1, 2026.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionShare Option (right to buy) · Derivative 40,997 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · derivative · entry 8

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 40,997 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The share options that were exercised in this reportable transaction were fully vested.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
SaleOrdinary Shares 22,500 $13.50 $303,750.00
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 7

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionOrdinary Shares 22,500 $2.83 $63,675.00
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 6

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
SaleOrdinary Shares 65,625 $13.75 $902,343.75
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 5

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionOrdinary Shares 65,625 $3.14 $206,062.50
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 4

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
SaleOrdinary Shares 40,997 $13.00 $532,961.00
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 3

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
Exercise / conversionOrdinary Shares 40,997 $2.48 $101,672.56
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 2

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:00 UTC
Francis ChrisSee Remarks
SaleOrdinary Shares 79,714 $14.00 $1,115,996.00
Disclosure

SEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 1

Francis Chris · CIK 0001657709 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Read SEC document
October 16, 2024 Filed Oct 19, 2024 00:00 UTC
BOLNO PAULDirector · President and CEO
SaleOrdinary Shares 90,474 $15.00 $1,357,110.00
Disclosure

SEC source: 0000950170-24-115725 · ownership.xml · nonDerivative · entry 1

BOLNO PAUL · CIK 0001657710 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,585

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024.

Read SEC document
October 11, 2024 Filed Oct 12, 2024 00:00 UTC
Moran KyleChief Financial Officer
Exercise / conversionShare Option (right to buy) · Derivative 25,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0000950170-24-114422 · ownership.xml · derivative · entry 2

Moran Kyle · CIK 0001657765 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 25,000 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Read SEC document
October 11, 2024 Filed Oct 12, 2024 00:00 UTC
Moran KyleChief Financial Officer
Exercise / conversionOrdinary Shares 25,000 $2.48 $62,000.00
Disclosure

SEC source: 0000950170-24-114422 · ownership.xml · nonDerivative · entry 1

Moran Kyle · CIK 0001657765 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,777

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 27, 2024 Filed Oct 1, 2024 21:54 UTC
GSK plc10% owner
PurchaseOrdinary Shares 2,791,930 $8.00 $22,335,440.00
Disclosure

SEC source: 0001999371-24-012789 · wve-form4_092724.xml · nonDerivative · entry 1

GSK plc · CIK 0001131399 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corporation

Disclosed balance after: 16,775,691

F1 · ownership.nature: The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.